International Consortium on Anti-Virals / Consortium International sur les Thérapies Antivirales

En FrançaisRead Our BlogContactHome

 

Follow ICAV-CITAV on Twitter

International Research Advisory Board (IRAB)

 

The IRAB provides external scientific guidance, oversight, and evaluation. The IRAB provides overall direction on ICAV’s scientific platform and evaluates specific ICAV scientific projects.

Jeremy Carver, BA, PhD
CEO & Co-founder, ICAV
Michel Chrétien, OC, OQ, CLH, MD,
Senior Scientist, Ottawa Health Research Institute; Co-founder, ICAV
Peter C. Doherty, PhD, AC, FAA, FAS
Professor of Biomedical Research and Chair of the Immunology Department, St Jude Children's Research Hospital, Tennessee; Laureate Professor, Department of Microbiology and Immunology, University of Melbourne
Donald Low, MD, FRCP
Microbiologist-in-Chief, Mt.Sinai Hospital, Toronto, Canada
Nabil G. Seidah, PhD, OQ, MRSC, MC
Director, Biochemical Neuroendocrinology Laboratory, Institut de recherches cliniques de Montréal, Montreal, Canada

Sir John Skehel (Chair), PhD, FRS, FMedSci
Former Director of the National Institute for Medical Research, Mill Hill, London, UK